Company announcement no 2026-07 | 8 April 2026 |
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2026-05, it was decided at Demant A/S’ ordinary general meeting on 5 March 2026 to reduce the company’s share capital by nominally DKK 408,274.40 divided into 2,041,372 shares of DKK 0.20, corresponding to the company’s holding of treasury shares as at 3 February 2026 less shares to cover share-based retention programmes for senior leadership and the Executive Board.
The capital reduction was published via the electronic information system of the Danish Business Authority on 6 March 2026. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 42,350,658.20.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 42,350,658.20
Number of voting rights: 211,753,291
Further information: Peter Pudselykke, Head of Investor Relations Gustav Høegh, Investor Relations Officer Maribel Alonso Francisco, Communication Manager
Phone +45 3917 7300 |
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.